Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.90
0.031.05%
At close: Nov 14, 4:00 PM EST
$2.98
0.082.76%
After Hours: Nov 14, 4:43 PM EST
Comments
Loading...
Cellectar Biosciences (CLRB) Stock Price, Quote, News & History
CLRBNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectar Biosciences (CLRB) stock?
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Who are Cellectar Biosciences (CLRB) competitors?
Other companies in Cellectar Biosciences’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Entero Therapeutics Inc (NASDAQ:ENTO) and Quoin Pharmaceuticals Ltd (NASDAQ:QNRX).
What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?
Cellectar Biosciences has a consensus price target of $28.00.
What is the current price for Cellectar Biosciences (CLRB)?
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.98 last updated November 14, 2025 at 4:43 PM EST.
Does Cellectar Biosciences (CLRB) pay a dividend?
There are no upcoming dividends for Cellectar Biosciences.
When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?
Cellectar Biosciences does not have any upcoming earnings scheduled.
Is Cellectar Biosciences (CLRB) going to split?
There is no upcoming split for Cellectar Biosciences.
What sector and industry does Cellectar Biosciences (CLRB) operate in?
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
